Did you know? Obesity is a chronic, relapsing neurobiological disease driven by dysregulation of appetite-regulating hormones and energy homeostasis. GLP-1 receptor agonism reduces caloric intake centrally and slows gastric emptying. In the STEP 1 trial, once-weekly semaglutide achieved sustained weight reductions with many patients losing more than 15% of body weight, along with meaningful improvements in cardiometabolic risk factors.
How has your framing of obesity as a chronic disease changed how you discuss treatment goals with patients?

How has your framing of obesity as a chronic disease changed how you discuss treatment goals with patients?
-
JOEL WASHINSKY4wIt's the #1 cause of death in the US. It requires lifelong treatment as does any chronic disease. -
Prasanthi Meagher1moI often refer to the weight loss clinic.